Abstract
The number of reports published on the follow-up data of patients with BD-IPMN has been increasing. Accumulating evidence from independent 12 studies revealed that the mean frequency of morphological changes of BD-IPMN, such as increased cyst size, increased MPD diameter, and/or appearance or enlargement of MNs, was 27.4 % (range, 14.9–61.8 %) of 1,293 followed-up patients (follow-up period, 2.6–8.1 years). Surgical resection was carried out in 9.9 % (range, 0–22.2 %) of all cases. Among the resected cases, 27.3 % were diagnosed histologically as malignant. During the follow-up period, malignant transformation was observed in only 2.7 %. BD-IPMNs without MNs have a low risk for malignant transformation regardless of cyst size at the initial diagnosis. Malignant transformation is associated with signs of progression especially appearance or enlargement of MNs and/or an increase in the MPD diameter. On the other hand, PDAC develops independently in the pancreas distinct from BD-IPMN. The mean frequency of PDAC occurrence was 2.8 % (range, 1.4–8.0 %) of all cases during the follow-up.
In conclusion, careful attention should be paid to the occurrence of PDAC in the entire pancreas in addition to progression of BD-IPMN when performing follow-up examinations in patients with BD-IPMN.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arlix A, Bournet B, Otal P, et al. Long-term clinical and imaging follow-up of nonoperated branch duct form of intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2012;41(2):295–301.
Bae SY, Lee KT, Lee JH, et al. Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas. Dig Liver Dis. 2012;44(3):257–60.
Guarise A, Faccioli N, Ferrari M, et al. Evaluation of serial changes of pancreatic branch duct intraductal papillary mucinous neoplasms by follow-up with magnetic resonance imaging. Cancer Imaging. 2008;8:220–8.
Ikeuchi N, Itoi T, Sofuni A, et al. Prognosis of cancer with branch duct type IPMN of the pancreas. World J Gastroenterol. 2010;16(15):1890–5.
Ingakul T, Sadakari Y, Ienaga J, et al. Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas. Ann Surg. 2010;251(1):70–5.
Kang MJ, Jang JY, Kim SJ, et al. Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms. Clin Gastroentrol Hepatol. 2011;9(1):87–93.
Kanno A, Satoh K, Hirota M, et al. Prediction of invasive carcinoma in branch type intraductal papillary mucinous neoplasms of the pancreas. J Gastroenterol. 2010;45(9):952–9.
Khannoussi W, Vullierme MP, Rebours V, et al. The long term risk of malignancy in patients with branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology. 2012;12(3):198–202.
Kobayashi G, Fujita N, Noda Y, et al. Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by EUS. J Gastroenterol. 2005;40(7):744–51.
Lee SH, Park JK, Woo SM, et al. Natural history of branch-duct type intraductal papillary mucinous neoplasms of the pancreas. Korean J Gastroenterol. 2007;49(1):24–30.
Maguchi H, Tanno S, Mizuno N, et al. Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas. A multicenter study in Japan. Pancreas. 2011;40(3):364–70.
Ohno E, Itoh A, Kawashima H, et al. Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself. Pancreas. 2012;41(6):855–62.
Pelaez-Luna M, Chari ST, Smyrk TC, et al. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol. 2007;102(8):1759–64.
Rautou PE, Lévy P, Vullierme MP, et al. Morphologic changes in branch duct intraductal papillary mucinous neoplasms of the pancreas: a midterm follow-up study. Clin Gastroenterol Hepatol. 2008;6(7):807–14.
Rodriguez JR, Salvia R, Crippa S, et al. Branch-duct intraductal papillary mucinous neoplasms: observation in 145 patients who underwent resection. Gastroenterology. 2007;133(1):72–9.
Sawai Y, Yamao K, Bhatia V, et al. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms. Endoscopy. 2010;42(12):1077–84.
Tada M, Kawabe T, Arizumi M, et al. Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients. Clin Gastroenterol Hepatol. 2006;4(10):1265–70.
Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6(1–2):17–32.
Tanaka M, Castillo CF, Adsay V, et al. International consensus guideline 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12(3):183–97.
Tang RS, Weinberg B, Dawson DW, et al. Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol. 2008;6(7):815–9.
Tanno S, Nakano Y, Nishikawa T, et al. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Gut. 2008;57(3):339–43.
Tanno S, Nakano Y, Sugiyama Y, et al. Incidence of synchronous and metachronous pancreatic carcinoma in 168 patients with branch duct intraductal papillary mucinous neoplasm. Pancreatology. 2010a;10(2–3):173–8.
Tanno S, Nakano Y, Koizumi K, et al. Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms. Pancreas. 2010b;39(1):36–40.
Uehara H, Nakaizumi A, Ishikawa O, et al. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut. 2008;57(11):1561–5.
Uehara H, Ishikawa O, Katayama K, et al. Size of mural nodule as an indicator of surgery for branch duct intraductal papillary mucinous neoplasm of the pancreas during follow-up. J Gastroenterol. 2011;46(5):657–63.
Yamaguchi K, Ohuchida J, Ohtsuka T, et al. Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology. 2002;2(5):484–90.
Yamaguchi K, Kanemitsu S, Hatori T, et al. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas. 2011;40(4):571–80.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Japan
About this chapter
Cite this chapter
Maguchi, H., Tanno, S. (2014). Natural History and Malignant Transformation of Branch Duct IPMN. In: Tanaka, M. (eds) Intraductal Papillary Mucinous Neoplasm of the Pancreas. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54472-2_3
Download citation
DOI: https://doi.org/10.1007/978-4-431-54472-2_3
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54471-5
Online ISBN: 978-4-431-54472-2
eBook Packages: MedicineMedicine (R0)